Exiqon A/Sn Completes Discovery Phase of Its Diagnostic Program for Early Detection of Colorectal Cancer in Blood

COPENHAGEN, Denmark, Dec. 20, 2010 (GLOBE NEWSWIRE) -- Exiqon A/S (Copenhagen:EXQ) today announced the completion of the discovery phase in its program for early detection of colorectal cancer (CRC) in blood. Exiqon and its partners at Copenhagen University, Aarhus University Hospital Skejby and Hvidovre Hospital have performed a two-phased discovery program in plasma samples from stage II/III CRC patients and age- and gender-matched colonoscopy-verified healthy controls.